(Q40456155)

20 September 2017

title

Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. (English)

1 reference

20 September 2017

1 reference

4

1 reference

20 September 2017

7

Nahum Sonenberg

1 reference

20 September 2017

5

Christophe Praud

1 reference

20 September 2017

Mickaël Ohanna

1

1 reference

20 September 2017

Andrew K Sobering

2

1 reference

20 September 2017

Thomas Lapointe

3

1 reference

20 September 2017

Emmanuel Petroulakis

6

1 reference

20 September 2017

Paul A Kelly

8

1 reference

20 September 2017

Athanassia Sotiropoulos

9

1 reference

20 September 2017

Mario Pende

10

1 reference

20 September 2017

publication date

20 February 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

7

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

286-294

1 reference

https://scigraph.springernature.com/pub.10.1038/ncb1231

20 September 2017

exact match

0 references

cites work

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

1 reference

7 January 2021

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

1 reference

7 January 2021

A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification

1 reference

7 January 2021

IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients

1 reference

7 January 2021

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

1 reference

7 January 2021

The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors

1 reference

7 January 2021

Molecular mechanisms modulating muscle mass

1 reference

7 January 2021

Identification of TOR signaling complexes: more TORC for the cell growth engine

1 reference

7 January 2021

Rheb fills a GAP between TSC and TOR.

1 reference

7 January 2021

The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways.

1 reference

7 January 2021

Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1)

1 reference

7 January 2021

Drosophila S6 kinase: a regulator of cell size

1 reference

7 January 2021

Regulation of cellular growth by the Drosophila target of rapamycin dTOR

1 reference

7 January 2021

The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila

1 reference

7 January 2021

Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E

1 reference

7 January 2021

mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E

1 reference

7 January 2021

S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway

1 reference

7 January 2021

Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice

1 reference

7 January 2021

Regulation of translation initiation by FRAP/mTOR

1 reference

7 January 2021

Role of Akt/protein kinase B in metabolism.

1 reference

7 January 2021

Differences in the way a mammalian cell and yeast cells coordinate cell growth and cell-cycle progression

1 reference

7 January 2021

Evidence for a size-sensing mechanism in animal cells

1 reference

7 January 2021

Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase

1 reference

7 January 2021

Identifiers

DOI

10.1038/NCB1231

1 reference

20 September 2017

1 reference